` CSBR (Champions Oncology Inc) vs S&P 500 Comparison - Alpha Spread

CSBR
vs
S&P 500

Over the past 12 months, CSBR has significantly outperformed S&P 500, delivering a return of 68% compared to the S&P 500's 9% growth.

Stocks Performance
CSBR vs S&P 500

Loading
CSBR
S&P 500
Add Stock

Performance Gap
CSBR vs S&P 500

Loading
CSBR
S&P 500
Difference
www.alphaspread.com

Performance By Year
CSBR vs S&P 500

Loading
CSBR
S&P 500
Add Stock

Competitors Performance
Champions Oncology Inc vs Peers

S&P 500
CSBR
0KHE
TMO
DHR
207940
Add Stock

Champions Oncology Inc
Glance View

Market Cap
115.1m USD
Industry
Life Sciences Tools & Services

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

CSBR Intrinsic Value
6.46 USD
Overvaluation 23%
Intrinsic Value
Price
Back to Top